BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32219156)

  • 1. Irreversible TrxR1 inhibitors block STAT3 activity and induce cancer cell death.
    Busker S; Qian W; Haraldsson M; Espinosa B; Johansson L; Attarha S; Kolosenko I; Liu J; Dagnell M; Grandér D; Arnér ESJ; Tamm KP; Page BDG
    Sci Adv; 2020 Mar; 6(12):eaax7945. PubMed ID: 32219156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To inhibit TrxR1 is to inactivate STAT3-Inhibition of TrxR1 enzymatic function by STAT3 small molecule inhibitors.
    Busker S; Page B; Arnér ESJ
    Redox Biol; 2020 Sep; 36():101646. PubMed ID: 32863208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of phenazine analogue as a novel scaffold for thioredoxin reductase I inhibitors against Hep G2 cancer cell lines.
    Liao J; Wang L; Wu Z; Wang Z; Chen J; Zhong Y; Jiang F; Lu Y
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1158-1163. PubMed ID: 31179772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent.
    Wang L; Yang Z; Fu J; Yin H; Xiong K; Tan Q; Jin H; Li J; Wang T; Tang W; Yin J; Cai G; Liu M; Kehr S; Becker K; Zeng H
    Free Radic Biol Med; 2012 Mar; 52(5):898-908. PubMed ID: 22210352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of novel derivatives of dithiodiglycolic acid prepared via oxidative coupling of thiols.
    Bakulina O; Bannykh A; Jovanović M; Domračeva I; Podolski-Renić A; Žalubovskis R; Pešić M; Dar'in D; Krasavin M
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):665-671. PubMed ID: 30746961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel electrophilic amides amenable by the Ugi reaction perturb thioredoxin system via thioredoxin reductase 1 (TrxR1) inhibition: Identification of DVD-445 as a new lead compound for anticancer therapy.
    Jovanović M; Zhukovsky D; Podolski-Renić A; Domračeva I; Žalubovskis R; Senćanski M; Glišić S; Sharoyko V; Tennikova T; Dar'in D; Pešić M; Krasavin M
    Eur J Med Chem; 2019 Nov; 181():111580. PubMed ID: 31400708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcuminoid B63 induces ROS-mediated paraptosis-like cell death by targeting TrxR1 in gastric cells.
    Chen X; Chen X; Zhang X; Wang L; Cao P; Rajamanickam V; Wu C; Zhou H; Cai Y; Liang G; Wang Y
    Redox Biol; 2019 Feb; 21():101061. PubMed ID: 30590310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The conserved Trp114 residue of thioredoxin reductase 1 has a redox sensor-like function triggering oligomerization and crosslinking upon oxidative stress related to cell death.
    Xu J; Eriksson SE; Cebula M; Sandalova T; Hedström E; Pader I; Cheng Q; Myers CR; Antholine WE; Nagy P; Hellman U; Selivanova G; Lindqvist Y; Arnér ES
    Cell Death Dis; 2015 Jan; 6(1):e1616. PubMed ID: 25611390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of thioredoxin reductase 1 by porphyrins and other small molecules identified by a high-throughput screening assay.
    Prast-Nielsen S; Dexheimer TS; Schultz L; Stafford WC; Cheng Q; Xu J; Jadhav A; Arnér ES; Simeonov A
    Free Radic Biol Med; 2011 May; 50(9):1114-23. PubMed ID: 21262347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53-dependent inhibition of TrxR1 contributes to the tumor-specific induction of apoptosis by RITA.
    Hedström E; Eriksson S; Zawacka-Pankau J; Arnér ES; Selivanova G
    Cell Cycle; 2009 Nov; 8(21):3584-91. PubMed ID: 19838062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluations of diverse Michael acceptor-based phenazine hybrid molecules as TrxR1 inhibitors.
    Zhong Y; Liu J; Cheng X; Zhang H; Zhang C; Xia Z; Wu Z; Zhang L; Zheng Y; Gao Z; Jiang Z; Wang Z; Huang D; Lu Y; Jiang F
    Bioorg Chem; 2021 Apr; 109():104736. PubMed ID: 33640630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin α-2 Expression, and Induce Antitumor Effects against Human Glioma.
    Miklossy G; Youn UJ; Yue P; Zhang M; Chen CH; Hilliard TS; Paladino D; Li Y; Choi J; Sarkaria JN; Kawakami JK; Wongwiwatthananukit S; Chen Y; Sun D; Chang LC; Turkson J
    J Med Chem; 2015 Oct; 58(19):7734-48. PubMed ID: 26331426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidation of structural cysteine residues in thioredoxin 1 by aromatic arsenicals enhances cancer cell cytotoxicity caused by the inhibition of thioredoxin reductase 1.
    Zhang X; Lu J; Ren X; Du Y; Zheng Y; Ioannou PV; Holmgren A
    Free Radic Biol Med; 2015 Dec; 89():192-200. PubMed ID: 26169724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: role of NF-E2-related factor-2.
    Sakurai A; Nishimoto M; Himeno S; Imura N; Tsujimoto M; Kunimoto M; Hara S
    J Cell Physiol; 2005 Jun; 203(3):529-37. PubMed ID: 15521073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial thioredoxin reductase inhibition, selenium status, and Nrf-2 activation are determinant factors modulating the toxicity of mercury compounds.
    Branco V; Godinho-Santos A; Gonçalves J; Lu J; Holmgren A; Carvalho C
    Free Radic Biol Med; 2014 Aug; 73():95-105. PubMed ID: 24816296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of thioredoxin reductase 1 by caveolin 1 promotes stress-induced premature senescence.
    Volonte D; Galbiati F
    EMBO Rep; 2009 Dec; 10(12):1334-40. PubMed ID: 19820694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.
    Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A
    Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer.
    Zou P; Xia Y; Ji J; Chen W; Zhang J; Chen X; Rajamanickam V; Chen G; Wang Z; Chen L; Wang Y; Yang S; Liang G
    Cancer Lett; 2016 May; 375(1):114-126. PubMed ID: 26963494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory nitrosylation of mammalian thioredoxin reductase 1: Molecular characterization and evidence for its functional role in cellular nitroso-redox imbalance.
    Engelman R; Ziv T; Arnér ESJ; Benhar M
    Free Radic Biol Med; 2016 Aug; 97():375-385. PubMed ID: 27377780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further exploration of DVD-445 as a lead thioredoxin reductase (TrxR) inhibitor for cancer therapy: Optimization of potency and evaluation of anticancer potential.
    Jovanović M; Zhukovsky D; Podolski-Renić A; Žalubovskis R; Dar'in D; Sharoyko V; Tennikova T; Pešić M; Krasavin M
    Eur J Med Chem; 2020 Apr; 191():112119. PubMed ID: 32087464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.